- May 26, 2021 Foghorn Therapeutics to Present in Two Upcoming Investor Conferences
- May 17, 2021 Foghorn Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Program of FHD-286
- May 11, 2021 Foghorn Therapeutics Provides Corporate Update
- Apr 28, 2021 Foghorn Therapeutics Appoints Ian Smith to its Board of Directors
- Mar 18, 2021 Foghorn Therapeutics Provides Corporate Update
- Mar 11, 2021 UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
- Feb 22, 2021 Foghorn Therapeutics to Participate in the 41st Cowen Annual Healthcare Conference
Displaying 11 - 17 of 17